DataMEDS AI, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MEDS | YI | HCTI | APUS | CCLD | ONMD | |
|---|---|---|---|---|---|---|
| Market cap | 8.70M | 27.36M | 6.46M | 7.85M | 82.44M | 22.89M |
| P/E (TTM) | — | 0.3 | — | — | 32.3 | — |
| Forward P/E | — | 22.2 | -0.6 | — | 4.3 | — |
| Price/book | -0.4 | -0.2 | 0.0 | 8.0 | 4.7 | -64.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −90.12% | −28.89% | −99.72% | −71.11% | −38.08% | −86.90% |
| Today | +3.72% | −1.27% | −10.70% | +3.59% | −3.00% | −8.60% |
The closest companies by business and industry (Medical Distribution). Prices may be delayed up to 15 min.
Latest news
All MEDS news ›DataMeds AI (MEDS) Stock Surges On Helomics Deal And GLP-1 App Momentum
DataMeds AI Inc. stocks have been trading up by 5.24 percent following strong sentiment around its latest AI healthcare breakthrough. MEDS has turned into a volatility magnet, and the numbers explain why. On the top line, DataMeds AI…
DataMeds AI (MEDS) Stock Rallies As AI Health Platform Gains Traction
DataMeds AI Inc. surged as a landmark FDA approval for its flagship diagnostic platform drove stocks have been trading up by 13.51 percent MEDS is trading like a classic high‑volatility story stock. Over the last few weeks, DataMeds AI has…
DataMeds AI Stock Surges As Revenue And Oncology Bets Ignite
DataMeds AI Inc. stocks have been trading up by 11.82 percent after unveiling a breakthrough healthcare diagnostics AI platform. MEDS has turned into a classic high‑volatility story name, but there is real revenue behind the hype. DataMeds…
DataMeds AI (MEDS) Stock Rockets On Oncology And GLP‑1 Momentum
DataMeds AI Inc. stocks have been trading up by 12.87 percent after breakthrough healthcare AI platform adoption boosted investor optimism. Key Takeaways For MEDS Traders Corexa Pharmacy topped $1M in preliminary September 2026 revenue,…
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test
DataMeds AI, Inc. MEDS shares are up on Monday as traders react to Medicaid coverage policy news tied to the company’s Helomics business and its ChemoFx assay. MEDS Stock Jumps on Humana Medicaid Coverage for ChemoFx DataMeds AI said…
DataMeds AI, Inc. (MEDS) Wins Humana Medicaid Coverage for ChemoFx
TradingView DataMeds AI, Inc. (MEDS) Wins Humana Medicaid Coverage for ChemoFx DataMeds AI said Humana added Helomics' ChemoFx assay (CPT 81535/81536) to its Medicaid Pharmacogenomics Testing policy for gynecologic cancers. Coverage is not…
Solventum collecting offers for Health Information Systems Business - Axios Pro
Solventum (SOLV), 3M’s spinoff, seeks bids for its Health Information Systems unit at a $5.5B–$7B valuation—get the latest deal update now. Solventum (SOLV), the 3M (MMM) spinoff that manufactures medical products and technology, is…
MEDS Stock Rockets As DataMeds AI Delivers Breakout Growth
DataMeds AI Inc. stocks have been trading up by 9.38 percent after securing a landmark multi-year hospital analytics partnership. DataMeds AI Inc. (MEDS) has turned into a volatility magnet. The stock ran from $0.86 on 2026/09/14 to an…
Holding Tech Group Launches Umbrella Data Practice
The Brandtech Group announced Monday the launch of a global data and artificial intelligence (AI) practice that combines more than 500 specialists across 22 countries that represents more than $100 million in revenue. The Brandtech Group…
MEDS Stock Surges As DataMeds AI Ignites AI Health Pivot
DataMeds AI Inc. stocks have been trading up by 8.67 percent after a groundbreaking healthcare AI partnership announcement. DataMeds AI (MEDS) has been trading like a biotech-on-news, not a sleepy pharmacy roll‑up. In mid‑September 2026,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com5
-
openpr.com4
-
stockstotrade.com4
-
timothysykes.com4
-
swoknews.com3
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 52 articles, not a forecast.